← Back to Search

Light Therapy

LED Light Therapy for Alopecia

N/A
Recruiting
Led By Amy McMichael, M.D.
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Women who are between the age of eighteen years and sixty-five years
Biopsy-proven diagnosis of CCCA Stage II-IV.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, month 2, month 4, month 6
Awards & highlights

Study Summary

This trial will examine if a cap w/LED light can stop hair loss & regrow hair in people w/Central centrifugal cicatricial alopecia. Participants will use the cap once daily for 10 mins.

Who is the study for?
This trial is for women aged 18-65 with a biopsy-proven diagnosis of Central centrifugal cicatricial alopecia (CCCA) stages II-IV. Participants must have been on stable treatment, such as doxycycline or minoxidil, without changes for at least 3 months. Men and those with other forms of hair loss are excluded.Check my eligibility
What is being tested?
The study tests the Revian Red All LED cap's effectiveness in treating CCCA by promoting hair growth or reducing inflammation. Participants will use the LED cap daily for a 10-minute session to see if it stops hair loss and encourages regrowth.See study design
What are the potential side effects?
Potential side effects are not explicitly mentioned but may include scalp irritation due to light exposure from the LED cap. Since this is a non-invasive treatment, severe side effects are unlikely.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a woman aged between 18 and 65.
Select...
My condition is confirmed as CCCA Stage II-IV through a biopsy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, month 2, month 4, month 6
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, month 2, month 4, month 6 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Shape of the hairline documented with photographs
Secondary outcome measures
Change in Breakage Assessments of hairline change by study physician
Change in Erythema Assessments of hairline change by study physician
Change in Hyperpigmentation Assessments of hairline change by study physician
+5 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: InterventionExperimental Treatment1 Intervention
Using the Revian Red All LED cap 10 minutes each day for 6 months

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor
1,242 Previous Clinical Trials
1,004,247 Total Patients Enrolled
Amy McMichael, M.D.Principal InvestigatorWake Forest University Health Sciences

Media Library

Revian Red All LED Cap (Light Therapy) Clinical Trial Eligibility Overview. Trial Name: NCT05759338 — N/A
Central Centrifugal Alopecia Research Study Groups: Intervention
Central Centrifugal Alopecia Clinical Trial 2023: Revian Red All LED Cap Highlights & Side Effects. Trial Name: NCT05759338 — N/A
Revian Red All LED Cap (Light Therapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05759338 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there an age limit for participants in this experiment?

"According to the trial's prerequisites, persons of legal age and up to 65 years old can participate."

Answered by AI

Who would make an ideal candidate for this clinical research?

"Those who wish to qualify for this trial must have central centrifugal cicatricial alopecia, and be between 18 and 65 years old. The team is currently enrolling 20 people in total."

Answered by AI

Is enrollment in this clinical trial still ongoing?

"As indicated on clinicaltrials.gov, this research project is not recruiting new participants at present. First posted on March 1st 2023 and recently updated February 24th 2023, the trial has reached its capacity. Nonetheless, there are still 85 other medical studies searching for patients to join them in their investigations."

Answered by AI
~4 spots leftby Jul 2024